Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study


Creative Commons License

Gutierrez-Gutierrez B., Bonomo R. A., Carmeli Y., Paterson D. L., Almirante B., Martinez-Martinez L., ...Daha Fazla

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, cilt.71, sa.6, ss.1672-1680, 2016 (SCI-Expanded, Scopus)

Özet

Objectives: Data about the efficacy of ertapenem for the treatment of bloodstream infections (BSI) due to ESBL-producing Enterobacteriaceae (ESBL-E) are Limited. We compared the clinical efficacy of ertapenem and other carbapenems in monomicrobial BSI due to ESBL-E.